Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Clinical trial NCT02179151 · TERMINATED
Trial details
- NCT number
- NCT02179151
- Sponsor
- Zafgen, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-12-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.